SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Thomas Jefferson

PatientThomas Jefferson
Date of birth1979-04-13
IdentifiersMRN HR-EN005-SYN; SSN (made up) 000-05-2276
Document date2026-06-18
AuthorNathaniel Beaumont-Ruiz, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review, four weeks after starting propranolol. [S]

History of Present Illness

Mr. Jefferson returns four weeks after starting propranolol 80 mg each evening. He felt a little tired in the first week, and that has passed; he has had no dizziness, wheeze or breathlessness on his walks. His diary shows 4 migraine days in the past four weeks, each treated with sumatriptan and naproxen; he was pain-free within two hours in three of the four attacks and back at work by midday. He used no other acute medicine, so his acute-medicine days total 4. The cold he had ten days ago has gone. His diary is missing three days during the cold. He has not yet seen the occupational therapist because of a waiting list, and writing remains slow; he has started using dictation for long reports. [S]

ElementDetail
Propranolol80 mg each evening for four weeks; tiredness in the first week only
Migraine days4 in the past four weeks, from 13 before prevention
Acute medicineSumatriptan with naproxen on 4 days; pain-free at two hours in 3 of 4
ColdResolved
Occupational therapyNot yet seen; waiting list

Review of Systems

SystemResultFinding
ConstitutionalNegativeTiredness of the first week has passed
RespiratoryNegativeNo wheeze or breathlessness
NeurologicalPositiveFour migraine attacks in four weeks; no new features
MusculoskeletalPositiveRight wrist stiff and sore after long writing

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen 500 mg oral tablet, one tablet with food at the start of a headache, may repeat once after 12 hours; no more than two days a weekOne tablet at headache onset, may repeat once after 12 hours; no more than two days a weekOral route2026-05-07activeS
Metoclopramide 10 mg oral tablet, one tablet with the naproxen when a headache brings nausea; no more than two days a weekOne tablet with the acute medicine when nausea is present, no more than once a dayOral route2026-05-07activeS
Sumatriptan 100 mg oral tablet, one tablet with naproxen early in a migraine attack, may repeat once after 2 hours; no more than two tablets a day and no more than nine days a monthOne tablet at attack onset with naproxen, may repeat once after 2 hours; up to 200 mg a dayOral route2026-05-21activeS
Propranolol extended-release 80 mg oral capsule, one capsule each evening, for migraine preventionOne capsule each eveningOral route2026-05-21 to 2026-06-18completedS
Propranolol extended-release 120 mg oral capsule, one capsule each evening, for migraine preventionOne capsule each eveningOral route2026-06-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-18Body height189cmS
2026-06-18Body weight76kgS
2026-06-18Body mass index (BMI) [Ratio]21.3kg/m2S
2026-06-18Systolic blood pressure116mm[Hg]S
2026-06-18Diastolic blood pressure74mm[Hg]S
2026-06-18Heart rate60/minS
2026-06-18Respiratory rate14/minS
2026-06-18Body temperature36.6CelS
2026-06-18Oxygen saturation in Arterial blood by Pulse oximetry98%S

Physical Exam

Vital signs recorded on 2026-06-18; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 116/74, pulse 60
NeurologicalNormal
MusculoskeletalRight wrist with reduced flexion and extension and a prominent ulnar head; finger joints swollen; grip weaker on the right

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent disabling headaches since early adulthood, in bouts lasting days to weeks, now in the seventh day of a bout; under evaluation, with a two-week headache diary and a headache medicine consultation; no red flagsresolvedconfirmed R51.9S — Synthetic presenting problem anchored to his documented periodical headaches; superseded when the consultation confirmed migraine without aura.
Migraine without aura, episodic, with bouts of near-daily attacks lasting two to three weeks; ICHD-3 criteria met in a two-week diary; synthetic modern diagnosis linked to his documented periodical headaches, which historians have usually but not unanimously called migraineactiveconfirmed G43.009S — Synthetic modern diagnosis made at the consultation; the historical diagnosis is disputed (CLM-0013), so this is not a claim about his real diagnosis.
Stiffness and weakness of the right wrist and hand after a dislocation that healed out of place in early middle age; writing is slow and painful after about an houractiveconfirmed M25.631S — Synthetic modern coding of the documented badly healed right wrist dislocation.
Common cold with nasal congestion and facial pressure, without bacterial sinusitis, early in propranolol prevention; resolvedresolvedconfirmed J00S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationRed-flag screen (SNNOOP10): systemic signs, neurological signs, sudden or new pattern, onset after 50, positional or Valsalva features, papilledema, progressive courseEvery visitCompleted todayNo red flags
SurveyHeadache diary: headache and migraine days, attack features, triggersEvery visitCompleted today4 migraine days in four weeks; three days missing during the cold
Medication safetyAcute-medicine days (medication overuse headache limits: triptan fewer than 10, NSAID fewer than 15 days a month)Every visitCompleted todayAcute medicine on 4 days in four weeks
Medication safetyAcute treatment response (pain-free at two hours, return to work)Every visitCompleted todayPain-free at two hours in 3 of 4 attacks with sumatriptan and naproxen
Medication safetyPropranolol tolerability: pulse, blood pressure, tiredness, exercise tolerance, wheeze, cold hands, sleepFour weeks after starting or changing the dose, then each visitCompleted todayPulse 60, blood pressure 116/74; tiredness in the first week only; no wheeze; dose raised to 120 mg
ExaminationPreventive efficacy (at least 50% fewer migraine days)At two to three months on an adequate doseDueFour weeks on 80 mg; efficacy judged at the three-month review
SurveyDisability (MIDAS, recorded as its five items, and HIT-6)At baseline and after about three months of preventionUp to dateRepeat at three months
SurveyMood (PHQ-9) and anxiety (GAD-7), including on a beta-blockerAt baseline, four to six weeks after starting a preventive that can affect mood, then at each reviewDeferredThe PHQ-9 planned four to six weeks after starting propranolol was not repeated today. No harm is evident: he reports a steady mood and no low mood or loss of interest on direct questions. Corrective action: PHQ-2 at the preventive visit and PHQ-9 and GAD-7 at the three-month review
ImagingNeuroimagingOnly for red flags or a change in patternNot indicatedNo red flags or change in pattern
Self-managementSleep, meals, caffeine and work-stress planEvery visitCompleted todayFixed wake time and regular lunch kept; walks most days
ReferralOccupational therapy visit for the right wrist and writingWithin four weeks of intakeDeferredNot seen four weeks after intake because of a waiting list. No harm so far beyond continued slow writing, eased by dictation. Corrective action: the clinic booked a hand therapist with an earlier opening

Goal progress:

Guideline basis: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024); The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice (2019); Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Preventive visit in four weeks. Three-month review in eight weeks. Diary continued. Next scheduled visit 2026-07-16: periodic adult preventive visit. [S]